Compounds > azacitidine

azacitidine and Erythremia

azacitidine has been researched along with Erythremia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Diamantopoulos, PT; Giannakopoulou, N; Hatzidavid, S; Viniou, NA1
Dasanu, CA; Lerner, J; Michel, M1
Anaclerico, B; Andriani, A; Aroldi, A; Breccia, M; Carmosino, I; Centra, A; Di Veroli, A; Elli, E; Fianchi, L; Foà, R; Latagliata, R; Martini, V; Montanaro, G; Montanaro, M; Niscola, P; Trapè, G; Villivà, N; Voso, MT1
Bhagat, TD; Bhattacharyya, S; Christopeit, M; Greally, JM; Maciejewski, JP; McDevitt, M; Melnick, AM; Mo, Y; Moliterno, A; Nischal, S; Pardanani, A; Sohal, D; Steidl, U; Suzuki, M; Verma, A; Will, B; Yu, Y; Zhou, L1
Angelillo-Scherrer, A; Blum, S1
Cortes, JE; Garcia-Manero, G; Kantarjian, H; Kornblau, S; Manshouri, T; Quintás-Cardama, A; Ravandi, F; Thomas, D; Tong, W; Verstovsek, S1

Trials

1 trial(s) available for azacitidine and Erythremia

ArticleYear
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis.
    Leukemia, 2008, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Azacitidine; DNA Methylation; Female; Humans; Janus Kinase 2; Male; Middle Aged; Neutropenia; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Treatment Outcome

2008

Other Studies

5 other study(ies) available for azacitidine and Erythremia

ArticleYear
Post-Myelofibrosis Acute Myeloid Leukemia Effectively Treated with a Combination of Ruxolitinib and 5-Azacytidine.
    Oncology research and treatment, 2019, Volume: 42, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Leukemia, Myeloid, Acute; Nitriles; Polycythemia Vera; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Treatment Outcome

2019
5-azacitidine reversing "spent" phase polycythemia vera back to proliferative phase and need for phlebotomy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:5

    Topics: Aged, 80 and over; Anemia; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Female; Humans; Myeloproliferative Disorders; Phlebotomy; Polycythemia Vera

2020
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.
    Hematological oncology, 2019, Volume: 37, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Melphalan; Middle Aged; Mutation; Myeloproliferative Disorders; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Remission Induction; Retrospective Studies; Thrombocythemia, Essential; Treatment Outcome

2019
Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms.
    Cancer research, 2013, Feb-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line, Tumor; Decitabine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Polycythemia Vera; Primary Myelofibrosis; Proto-Oncogene Proteins; Repressor Proteins; Thrombocythemia, Essential

2013
Block of red blood cell maturation in acute erythroid leukemia.
    Blood, 2012, Sep-06, Volume: 120, Issue:10

    Topics: Antigens, CD; Azacitidine; Blood Cell Count; Cell Differentiation; Erythroblasts; Fatal Outcome; Humans; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Pancytopenia; Polycythemia Vera; Reticulocytes

2012